Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Aquestive Therapeutics Inc (AQST)
Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 175,597
  • Shares Outstanding, K 66,767
  • Annual Sales, $ 47,680 K
  • Annual Income, $ -54,410 K
  • 60-Month Beta 2.78
  • Price/Sales 3.20
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AQST with:

Options Overview Details

View History
  • Implied Volatility 154.64% ( +12.37%)
  • Historical Volatility 56.35%
  • IV Percentile 63%
  • IV Rank 10.52%
  • IV High 1,026.52% on 04/25/23
  • IV Low 52.14% on 11/07/23
  • Put/Call Vol Ratio 0.21
  • Today's Volume 437
  • Volume Avg (30-Day) 315
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 6,461
  • Open Int (30-Day) 6,733

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.08
  • Number of Estimates 3
  • High Estimate -0.04
  • Low Estimate -0.11
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +65.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.32 +10.78%
on 01/25/24
2.95 -12.88%
on 02/06/24
+0.07 (+2.80%)
since 01/23/24
3-Month
1.84 +39.67%
on 12/21/23
2.95 -12.88%
on 02/06/24
+0.53 (+25.98%)
since 11/22/23
52-Week
0.72 +256.94%
on 03/15/23
2.95 -12.88%
on 02/06/24
+1.76 (+215.57%)
since 02/23/23

Most Recent Stories

More News
Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics: Q3 Earnings Snapshot

AQST : 2.57 (-2.28%)
Aquestive Therapeutics: Q2 Earnings Snapshot

Aquestive Therapeutics: Q2 Earnings Snapshot

AQST : 2.57 (-2.28%)
3 Smart Money Stocks to Invest in Today

Fears of an impending recession have kept the stock market volatile. Therefore, it could be wise to invest in quality stocks APi Group (APG), Amphastar Pharmaceuticals (AMPH), and Aquestive Therapeutics...

AMPH : 53.41 (+2.89%)
APG : 35.27 (+0.46%)
AQST : 2.57 (-2.28%)
Best Momentum Stocks to Buy for May 9th

AQST, PLTK and WWD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 9, 2023.

WWD : 139.26 (+0.15%)
AQST : 2.57 (-2.28%)
PLTK : 7.20 (-0.69%)
New Strong Buy Stocks for May 9th

SBGI, AQST, PLTK, GTX and LRMR have been added to the Zacks Rank #1 (Strong Buy) List on May 9, 2023

SBGI : 14.59 (-1.29%)
AQST : 2.57 (-2.28%)
GTX : 9.42 (+1.29%)
LRMR : 12.12 (+3.59%)
PLTK : 7.20 (-0.69%)
Aquestive Therapeutics (AQST) Tops Q1 Earnings and Revenue Estimates

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of 210% and 9.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AQST : 2.57 (-2.28%)
ZTS : 197.21 (+0.28%)
Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics: Q1 Earnings Snapshot

AQST : 2.57 (-2.28%)
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Neurocrine (NBIX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NBIX : 134.18 (+0.61%)
AQST : 2.57 (-2.28%)
Assertio (ASRT) to Report Q1 Earnings: What's in the Cards?

On Assertio Therapeutics' (ASRT) Q1 earnings call, investors will likely focus on the sales performance of its rheumatology, pain and inflammation medicines.

RETA : 172.36 (+0.02%)
ASRT : 0.8200 (+1.86%)
AQST : 2.57 (-2.28%)
CELU : 0.4644 (+7.13%)
Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -9.52% and 7.57%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

AQST : 2.57 (-2.28%)
ONCT : 9.04 (-1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based...

See More

Key Turning Points

3rd Resistance Point 2.90
2nd Resistance Point 2.84
1st Resistance Point 2.70
Last Price 2.57
1st Support Level 2.50
2nd Support Level 2.44
3rd Support Level 2.30

See More

52-Week High 2.95
Last Price 2.57
Fibonacci 61.8% 2.10
Fibonacci 50% 1.84
Fibonacci 38.2% 1.57
52-Week Low 0.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar